Get notified when SLXN files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsSilexion Therapeutics files 424B3 prospectus; ordinary shares last traded at $3.06, warrants at $0.03
Filed June 18, 2026 · ~1 min read
Key Changes
-
medium
The prospectus discloses last reported sales prices of $3.06 per ordinary share and $0.03 per warrant as of June 10, 2026.
The Offering verify on EDGAR →
This preview is just the start — the full report includes the narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (FPS 10-K) is open in full — no account needed.
Partner
Trade SLXN commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Sep 2, 2026 · How we verify